). Item 7.01. Regulation FD Disclosure. On March 20, 2026, EyePoint, Inc. (the "Company") filed a complaint against Ocular Therapeutix, Inc ...Gen. L. c. 93A, §§ 2 and 11, and tortious interference with advantageous business relations ...Disclaimer.
). SARASOTA, FL, March 20,2026 - Helios Technologies, Inc. (NYSE... "The CORE 2030 Strategy leverages our unique MomentumModel positioning Helios to deliver sustainable, profitable growth and drive value creation for our shareholders." ... NEWS.